PROTRANS Trademark

Trademark Overview

On Tuesday, May 17, 2016, a trademark application was filed for PROTRANS with the United States Patent and Trademark Office. The USPTO has given the PROTRANS trademark a serial number of 87039222. The federal status of this trademark filing is REGISTERED as of Tuesday, April 23, 2019. This trademark is owned by Cellaviva AB. The PROTRANS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
protrans

General Information

Serial Number87039222
Word MarkPROTRANS
Filing DateTuesday, May 17, 2016
Status700 - REGISTERED
Status DateTuesday, April 23, 2019
Registration Number5734261
Registration DateTuesday, April 23, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
Pseudo MarkPRO TRANS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 20, 2016
Primary Code005
First Use Anywhere DateTuesday, November 1, 2016
First Use In Commerce DateTuesday, November 1, 2016

Trademark Owner History

Party NameCellaviva AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHuddinge 14157
SE
Party NameCellaviva AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHuddinge 14157
SE
Party NameCellaviva AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHuddinge 14157
SE

Trademark Events

Event DateEvent Description
Tuesday, April 23, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 19, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 18, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 13, 2019ASSIGNED TO LIE
Tuesday, March 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 28, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 28, 2019NON-FINAL ACTION E-MAILED
Monday, January 28, 2019SU - NON-FINAL ACTION - WRITTEN
Saturday, January 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 4, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, December 10, 2018USE AMENDMENT FILED
Sunday, December 9, 2018EXTENSION 3 GRANTED
Wednesday, June 27, 2018EXTENSION 3 FILED
Tuesday, December 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 13, 2018NOTICE OF REVIVAL - E-MAILED
Thursday, December 13, 2018NOTICE OF REVIVAL - E-MAILED
Thursday, December 13, 2018PETITION GRANTED - SOU FILED
Monday, December 10, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 10, 2018TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Friday, November 16, 2018INCOMPLETE PETITION NOTICE MAILED
Tuesday, November 13, 2018ASSIGNED TO PETITION STAFF
Saturday, September 8, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 13, 2018NOTICE OF REVIVAL - E-MAILED
Monday, August 13, 2018TEAS STATEMENT OF USE RECEIVED
Monday, August 13, 2018EXTENSION RECEIVED WITH TEAS PETITION
Monday, August 13, 2018PETITION TO REVIVE-GRANTED
Monday, August 13, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, July 30, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 30, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, December 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 27, 2017EXTENSION 2 GRANTED
Wednesday, December 27, 2017EXTENSION 2 FILED
Wednesday, December 27, 2017TEAS EXTENSION RECEIVED
Thursday, June 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 27, 2017EXTENSION 1 GRANTED
Tuesday, June 27, 2017EXTENSION 1 FILED
Tuesday, June 27, 2017TEAS EXTENSION RECEIVED
Tuesday, December 27, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 26, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 21, 2016ASSIGNED TO LIE
Wednesday, September 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, September 7, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 7, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, September 7, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, September 1, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 1, 2016NON-FINAL ACTION E-MAILED
Thursday, September 1, 2016NON-FINAL ACTION WRITTEN
Thursday, September 1, 2016ASSIGNED TO EXAMINER
Saturday, May 21, 2016NOTICE OF PSEUDO MARK E-MAILED
Friday, May 20, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 20, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

protrans system disorders treatment hematology oncology tissue inflammatory dermatology genitourinary ophthalmology